MOREPENLAB.BO

Healthcare Drug Manufacturers - Specialty & Generic

Morepen Laboratories Limited

₹135.30
+1.40 +1.05% today

Price History

Not enough data

Key Stats

Market Cap
74.14B
Avg Volume
—
P/E (TTM)
75.59
EPS
₹1.79
52W High
₹137.50
52W Low
₹33.47
Div. Yield
0.0%

Valuation

P/B Ratio
6.21
P/S Ratio
4.22
EV/EBITDA
17.75
EV/Revenue
1.23

Margins

Gross Margin 33.9%
Operating Margin 5.8%
Net Margin 5.7%
EBITDA Margin 6.9%

Growth & Returns

Revenue Growth (YoY)
(6.0%)
Earnings Growth (YoY)
15.4%
Earnings Growth (QoQ)
18.3%
Return on Equity
8.6%
Return on Assets
3.5%

Liquidity & Leverage

Current Ratio
2.23
Quick Ratio
0.76
Debt / Equity
0.13
Total Cash
808.74M
Total Debt
1.58B

About

Morepen Laboratories Limited develops, manufactures, markets, and sells active pharmaceutical ingredients (APIs), branded and generic formulations, and home health products in India, the United States, and internationally. The company offers APIs for anti-histaminic, anti-asthmatic, anti-lipemic, anti-hypertensive, anti-diabetic, anti-coagulant, anti-ulcerative, and anti-depressant drugs; and home diagnostic products, such as air purifiers, sphygmomanometers, blood glucose test strips, blood pressure monitors, breathe free vaporizers, stethoscopes, digital thermometers, blood glucose monitors, nebulizers, heat belts, and pulse oximeters. It also provides OTC and healthcare products, including fever X for fever; Pain X for pain; Fiber-X for constipation; sat isabgol; Acidity X for acidity; Burnol, a first degree/minor burns cream; and formulations for nutrition and probiotics, gastroenterology, antibiotics, gynecology, anti-allergic, and central nervous system, as well as cardiology, diabetology, and nutraceuticals. The company offers over the counter products under the Dr. Morepen brand name. Morepen Laboratories Limited was incorporated in 1984 and is based in Gurugram, India.

www.morepen.com